|
|
 |
Reverse Transcriptase Inhibitors in HIV/AIDS Therapy |  | | | | | | DRM Restrictions | | Printing | Not allowed | | Copy to clipboard | Not allowed |
|  |  |  | Table of contents
1. Structural Studies on HIV Reverse Transcriptase Related to Drug Discovery David K. Stammers, Jingshan Ren
2. Zidovudine, Lamivudine, and Abacavir Monica Carten, Harold Kessler
3. Stavudine, Didanosine, and Zalcitabine Gail Skowron, Sapna Chowdhry, Michael R. Stevens
4. Emtricitabine Gail Skowron, Jeffrey Bratberg, Rudi Pauwels
5. Nucleotide Analogs Craig J Hoesley
6. Resistance to Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Nancy Shulman, Mark Winters
7. Pharmacokinetics of Reverse Transcriptase Inhibitors Patrick Hoggard, Stephen Kewn, Saye Khoo, David Back
8. Peripheral Neuropathy Associated With Nucleoside Reverse Transcriptase Inhibitor Therapy Bruce A. Cohen, Russell Bartt
9. Mitochondrial Dysfunction and Nucleoside Reverse Transcriptase Inhibitor Therapy William Lewis
10. Mitochondrial Toxicity and Lipodystrophy Grace McComsey
11. Nevirapine David Asmuth, Richard Pollard
12. Efavirenz Graeme J. Moyle, Brian Conway
13. Delavirdine Brian Conway
14. Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors F. Ramzi Asfour, Richard Haubrich
15. Vertical Transmission of HIV and Therapeutic Interventions Susan Cu-Uvin, Arlene Bardeguez, Carla Chibwesha
16. New Reverse Transcriptase Inhibitors in Development Rudi Pauwels
17. Antiretroviral Drugs for Millions Allan Ronald, Elly Katabira, Merle Sande
DRM-restrictions
Printing: not available Clipboard copying: not available
| | | | We do not deliver the extra material sometimes included in printed books (CDs or DVDs). |
|
|
Shopping cart
There are no products in your shopping cart.
|